The Drum Awards Festival - Official Deadline

-d -h -min -sec

GSK Marketing

GlaxoSmithKline reviews global media account


By John Glenday, Reporter

May 8, 2018 | 2 min read

Global pharmaceuticals giant GlaxoSmithKline has placed its entire media account under review, three years on from awarding the business to Omnicom’s PHD and WPP’s Mediacom.

Glaxosmithkline publicis

GlaxoSmithKline reviews giant global media account / Glaxosmithkline

According to Ad Age the reappraisal potentially puts a $1.7bn advertising budget up for grabs and comes as part of a mandatory three-year cycle of reviews at the behest of GSK management.

Any changes are likely to be driven by cost concerns with GSK increasingly keen to strengthen its bottom line amidst a decline in its stock price.

Last year GSK signed a deal with Publicis Groupe, WPP and IPG as part of efforts to consolidate global ad duties to nine businesses.

GSK’s media pitch is being managed by ID Comms.

GSK Marketing

Content created with:


Find out more

More from GSK

View all


Industry insights

View all
Add your own content +